Table 2.
Hospitalisation (%) of SARS-COV-2 PCR positive cases (18 + Ages) after Jan 30th.
| Vaccine type | Total rate (hospitalisation) | > 50 rate (hospitalisation) | < 50 rate (hospitalisation) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Rate (Total) | LCL UCL |
OR | Rate (Total) | LCL UCL |
OR | Rate (Total) | LCL UCL |
OR | |
| Unvaccinated |
13.66 (8340) |
13.30 14.02 |
NA |
32.79 (3440) |
31.62 33.98 |
NA |
9.69 (4900) |
9.35 10.03 |
NA |
| Sinopharm |
6.94 (1683) |
6.53 7.37 |
2.12 |
16.1 (1081) |
14.97 17.27 |
2.54 |
3.43 (602) |
3.09 3.8 |
3.02 |
| Sputnik V |
2.24 (77) |
1.66 2.96 |
6.89 |
11.87 (45) |
8.07 16.62 |
3.62 |
1.05 (32) |
0.65 1.6 |
10.13 |
| Pfizer-BioNtech |
1.99 (40) |
1.30 2.91 |
7.78 |
4.85 (21) |
2.67 8.01 |
9.57 |
1.21 (19) |
0.64 2.07 |
8.78 |
| Covishield |
1.52 (45) |
1.02 2.18 |
10.2 |
4.19 (24) |
2.4 6.73 |
11.16 |
0.88 (21) |
0.48 1.48 |
12.05 |
*In pairwise comparison to unvaccinated, all p values < 0.001.